AstraZeneca on Thursday forecast 2021 revenue growth after the COVID19 vaccine developer beat analysts' estimates for fourthquarter product sales, as a wide range of therapies helped cushion the hit from the pandemic.from Top Business News- News18.com https://ift.tt/3a5uNH0
